Literature DB >> 3149775

Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of d-amphetamine and apomorphine.

P B Clarke1, A Jakubovic, H C Fibiger.   

Abstract

Lesion studies employing 6-hydroxydopamine (6-OHDA) suggest that locomotor hyperactivity induced by certain stimulant drugs is dependent on dopaminergic neurotransmission in the nucleus accumbens (NACC). However, studies to date have not adequately controlled for the reported effects of 6-OHDA on baseline (non-drug) activity and on DA levels in other terminal regions. Slow bilateral infusions of 6-OHDA into the NACC, but not into olfactory tubercle (OT) or medial prefrontal cortex (mPFCx), reduced d-amphetamine (0.5 mg/kg SC) hyperactivity and resulted in a "supersensitive" (hyperactive) response to a low dose of apomorphine (0.1 mg/kg SC) in photocell cages. Direct observation revealed no behavioral changes in OT lesioned rats challenged with apomorphine which might correspond to a "denervation supersensitivity" syndrome. Assays of DA and 5-hydroxytryptamine (5-HT) in mPFCx, OT, NACC, and caudate-putamen revealed that 6-OHDA infusion into NACC caused substantial DA loss in NACC, OT and mPFCx, whereas infusion at mPFCx or OT sites depleted DA locally (greater than 85% loss) with little or no remote change. Concentrations of 5-HT were little altered by 6-OHDA, except for a local depletion in mPFCx. The present results confirm the importance of nucleus accumbens DA in the expression of locomotor stimulation induced by apomorphine and d-amphetamine, and suggest that the mPFCx and OT do not make an important contribution.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3149775     DOI: 10.1007/bf02180033

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  6-Hydroxydopamine lesions of the medial prefrontal cortex fail to influence intravenous self-administration of cocaine.

Authors:  M T Martin-Iverson; C Szostak; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Mesolimbic dopamine and its control of locomotor activity in rats: differences in pharmacology and light/dark periodicity between the olfactory tubercle and the nucleus accumbens.

Authors:  A R Cools
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 3.  The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings.

Authors:  N R Swerdlow; F J Vaccarino; M Amalric; G F Koob
Journal:  Pharmacol Biochem Behav       Date:  1986-07       Impact factor: 3.533

4.  Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat.

Authors:  A J Pijnenburg; W M Honig; J M Van Rossum
Journal:  Psychopharmacologia       Date:  1975

5.  Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.

Authors:  B Castall; C D Marsden; R J Naylor; C J Pycock
Journal:  Brain Res       Date:  1977-03-04       Impact factor: 3.252

6.  Abnormal pattern of amphetamine locomotion after 6-OHDA lesion of anteromedial caudate.

Authors:  J S Fink; G P Smith
Journal:  Pharmacol Biochem Behav       Date:  1979-07       Impact factor: 3.533

7.  Intracortical 6-hydroxydopamine induced an asymmetrical behavioral response in the rat.

Authors:  R G Robinson; T G Stitt
Journal:  Brain Res       Date:  1981-06-01       Impact factor: 3.252

8.  Effect of injections of 6-OHDA into either nucleus accumbens septi or frontal cortex on spontaneous and drug-induced activity.

Authors:  E M Joyce; L Stinus; S D Iversen
Journal:  Neuropharmacology       Date:  1983-09       Impact factor: 5.250

9.  The effects of nicotine on locomotor activity in non-tolerant and tolerant rats.

Authors:  P B Clarke; R Kumar
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

10.  Behavioural responses to stereotactically controlled injections of monoamine neurotransmitters into the accumbens and caudate-putamen nuclei.

Authors:  R O Makanjuola; R C Dow; G W Ashcroft
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  21 in total

1.  Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse.

Authors:  Nicole M Enman; Ellen M Unterwald
Journal:  Behav Brain Res       Date:  2012-05-16       Impact factor: 3.332

2.  The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine.

Authors:  W A Corrigall; K B Franklin; K M Coen; P B Clarke
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Stimulation of D2 receptors in the prefrontal cortex reduces PCP-induced hyperactivity, acetylcholine release and dopamine metabolism in the nucleus accumbens.

Authors:  A Del Arco; F Mora; A H Mohammed; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575

4.  A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.

Authors:  L H Gold; C B Hubner; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Locomotor responses to benzodiazepines, barbiturates and ethanol in diazepam-sensitive (DS) and -resistant (DR) mice.

Authors:  T J Phillips; E J Gallaher
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.

Authors:  P B Clarke; K J Wyder; A Jakubovic; H C Fibiger
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

7.  Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone.

Authors:  Chi-Tso Chiu; Tangeng Ma; Ing K Ho
Journal:  Brain Res Bull       Date:  2005-09-30       Impact factor: 4.077

8.  Bilateral six-hydroxydopamine administration to PFC prevents the expression of behavioral sensitization to methylphenidate.

Authors:  S J Wanchoo; M J Lee; A C Swann; N Dafny
Journal:  Brain Res       Date:  2009-11-22       Impact factor: 3.252

9.  Comparison of systemic and local methamphetamine treatment on acetylcholine and dopamine levels in the ventral tegmental area in the mouse.

Authors:  L K Dobbs; G P Mark
Journal:  Neuroscience       Date:  2008-08-03       Impact factor: 3.590

10.  Dopamine depletion augments endogenous opioid-induced locomotion in the nucleus accumbens using both mu 1 and delta opioid receptors.

Authors:  L Churchill; B P Roques; P W Kalivas
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.